This is precisely the sort of advance that Bobby Measles is trying to prevent when he cuts funding for mRNA-based vaccines and treatments.
nbcnews.com
Pancreatic cancer mRNA vaccine shows lasting results in an early trial
Scientists caution that more research is needed, but nearly all of the patients who responded to the personalized vaccine are still alive six years later.
